Evolved Vulnerability to Addiction: The Problem of Opiates

  • Elizabeth M. HillEmail author
  • Lindsey Hunt
  • Daniel G. Duryea
Part of the Evolutionary Psychology book series (EVOLPSYCH)


According to the Centers for Disease Control and Prevention (CDC), 2015 marked the record for drug overdoses in the United States as more than 33,000 individuals died from an overdose of heroin or synthetic opioids, with nearly half of these deaths attributed to prescription opioids. CDC estimates indicate that 60% of all drug overdose deaths involve opioids. Since 1999, opioid overdose has nearly quadrupled with more than half a million deaths documented between 2000 and 2015. Current estimates suggest that 91 citizens perish daily from opioid overdose (CDC, 2016).


Addiction Substance abuse Opiates Evolved vulnerability Darwinian medicine Evolution Mental disorders Psychopathology 


  1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5 th edition): DSM-5. Arlington, VA: American Psychiatric Association.CrossRefGoogle Scholar
  2. Apkarian, A. V., Bushnell, M. C., Treede, R. D., & Zubieta, J. K. (2005). Human brain mechanisms of pain perception and regulation in health and disease. European Journal of Pain, 9(4), 463–463.CrossRefPubMedGoogle Scholar
  3. Baumgärtner, U., Buchholz, H. G., Bellosevich, A., Magerl, W., Siessmeier, T., Rolke, R., … Schreckenberger, M. (2006). High opiate receptor binding potential in the human lateral pain system. NeuroImage, 30(3), 692–699.CrossRefPubMedGoogle Scholar
  4. Beck, A. K., Wright, F. D., Newman, C. F., & Liese, B. S. (1993). Cognitive therapy of substance abuse. New York: Guilford Press.Google Scholar
  5. Beer, B., Erb, R., Pavlic, M., Ulmer, H., Giacomuzzi, S., Riemer, Y., & Oberacher, H. (2013). Association of polymorhphisms in pahrmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: A case-control study. PloS One, 9(9), e75359.CrossRefGoogle Scholar
  6. Berridge, K. C. (1996). Food reward: Brain substrates of wanting and liking. Neuroscience and Biobehavioral Reviews, 20(1), 1–25.CrossRefPubMedGoogle Scholar
  7. Bickel, W. K., & Johnson, M. W. (2003). Delay discounting: A fundamental behavioral process of drug dependence. In G. Loewenstein, D. Read, & R. Baumeister (Eds.), Time and decision: Economic and psychological perspectives on intertemporal choice (pp. 419–440). New York, NY: Russell Sage.Google Scholar
  8. Bohnert, A. S. B., Valenstein, M., Bair, M. J., Ganoczy, D., McCarthy, J. F., Ilgen, M. A., & Blow, F. C. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. Journal of the American Medical Association, 305, 1315–1321.CrossRefPubMedGoogle Scholar
  9. Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., … Tischfield, J. A. (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proceedings of the National Academy of Sciences, USA, 95, 9608–9613.CrossRefGoogle Scholar
  10. Branchi, I., Santucci, D., & Alleva, E. (2001). Ultrasonic vocalisation emitted by infant rodents: A tool for assessment of neurobehavioural development. Behavioural Brain Research, 125, 49–56.CrossRefPubMedGoogle Scholar
  11. Brownstein, M. J. (1993). A brief history of opiates, opioid peptides, and opioid receptors. Proceedings of the National Academy of Sciences, 90(12), 5391–5393.CrossRefGoogle Scholar
  12. Center for Substance Abuse Treatment (CSAT). (2005). Medication assisted treatment for opioid addiction in opioid addiction programs (treatment improvement protocols [TIP] series 43, [SMA] 05–4018). Rockville, MD: SAMHSA.Google Scholar
  13. Centers for Disease Control and Prevention. (2016). Injury prevention & control: Opioid overdose. Retrieved December 20, 2016, from
  14. Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry, 71(7), 821–826.CrossRefPubMedGoogle Scholar
  15. Degenhardt, L., Charlson, F., Mathers, B., Hall, W. D., Flaxman, A. D., Johns, N., & Vos, T. (2014). The global epidemiology and burden of opioid dependence: Results from the global burden of disease 2010 study. Addiction, 109(8), 1320–1333.CrossRefPubMedGoogle Scholar
  16. DiClemente, C. C. (2003). Addiction and change: How addictions develop and addicted people recover. New York: Guilford Press.Google Scholar
  17. Dodrill, C. L., Helmer, D. A., & Kosten, T. R. (2011). Prescription pain medication dependence. American Journal of Psychiatry, 168(5), 466–471.CrossRefPubMedGoogle Scholar
  18. Dunbar, R. I. M. (2010). The social role of touch in humans and primates: Behavioral function and neurobiological mechanisms. Neuroscience and Biobehavioral Reviews, 34, 260–268.CrossRefPubMedGoogle Scholar
  19. Dunbar, R. I. M., Teasdale, B., Thompson, J., Budelmann, F., Duncan, S., van Emde Boas, E., & Maguire, L. (2016). Emotional arousal while watching drama increases pain threshold and social bonding. Royal Society Open Science, 3, 160288.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Edenberg, H. J. (2007). The genetics of alcohol metabolism: Role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Research & Health, 30(1), 5–14.Google Scholar
  21. Edwards, R. R., Wasan, A. D., Michna, E., Greenbaum, S., Ross, E., & Jamison, R. N. (2011). Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. The Journal of Pain, 12, 953–963.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Eisenberger, N. I. (2012). The pain of social disconnection: Examining the shared neural underpinnings of physical and social pain. Nature Reviews: Neuroscience, 13, 421–434.CrossRefPubMedGoogle Scholar
  23. Eisenberger, N. I. (2015). Social pain and the brain: Controversies, questions, and where to go from here. Annual Review of Psychology, 66, 601–629.CrossRefPubMedGoogle Scholar
  24. Eisenberger, N. I., Lieberman, M. D., & Williams, K. D. (2003). Does rejection hurt? An fMRI study of social exclusion. Science, 302, 290–292.CrossRefPubMedGoogle Scholar
  25. Fabre-Nys, C., Meller, R. E., & Keverne, E. B. (1982). Opiate antagonists stimulate affiliative behaviour in monkeys. Pharmacology, Biochemistry, and Behavior, 16(4), 653–659.CrossRefPubMedGoogle Scholar
  26. Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W., Simonin, F., … Kieffer, B. L. (2000). Mice deficient for δ-and μ-opioid receptors exhibit opposing alterations of emotional responses. Nature Genetics, 25(2), 195–200.CrossRefPubMedGoogle Scholar
  27. Food & Drug Administration (FDA). (2016). FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use. Retrieved December 20, 2016, from,
  28. Friedman, E. G. (2014). Assessment and treatment of individuals dependent on opioids. In S. L. Ashenberg Straussner (Ed.), Clinical work with substance-abusing clients (pp. 88–109). New York: Guilford Press.Google Scholar
  29. Goldstein, A. (1987). Binding selectivity profiles for ligands of multiple receptor types: Focus on opioid receptors. Trends in Pharmacological Sciences, 8(12), 456–459.CrossRefGoogle Scholar
  30. Green, T. C., Black, R., Serrano, J. M. G., Budman, S. H., & Butler, S. F. (2011). Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. PloS One, 6(11), e27244.CrossRefPubMedPubMedCentralGoogle Scholar
  31. Heilig, M., Epstein, D. H., Nader, M. A., & Shaham, Y. (2016). Time to connect: Bringing social context into addiction neuroscience. Nature Reviews: Neuroscience, 17(9), 592. doi: 10.1038/nrn.2016.67.CrossRefPubMedPubMedCentralGoogle Scholar
  32. Henriksen, G., & Willoch, F. (2008). Imaging of opioid receptors in the central nervous system. Brain, 131, 1171–1196.CrossRefPubMedGoogle Scholar
  33. Hill, E. M., & Chow, K. (2002). Life-history theory and risky drinking. Addiction, 97, 401–413.CrossRefPubMedGoogle Scholar
  34. Hsu, D. T., Sanford, B. J., Meyers, K. K., Love, T. M., Hazlett, K. E., Wang, H., … Zubieta, J.-K. (2013). Response of the μ-opioid system to social rejection and acceptance. Molecular Psychiatry, 18, 1211–1217.CrossRefPubMedPubMedCentralGoogle Scholar
  35. Kalin, N. H., Shelton, S. E., & Barksdale, C. M. (1988). Opiate modulation of separation-induced distress in non-human primates. Brain Research, 440, 285–292.CrossRefPubMedGoogle Scholar
  36. Kennedy, S. E., Koeppe, R. A., Young, E. A., & Zubieta, J. K. (2006). Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Archives of General Psychiatry, 63(11), 1199–1208.CrossRefPubMedGoogle Scholar
  37. Kirby, K. N., & Petry, N. M. (2004). Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction, 99, 461–471.CrossRefPubMedGoogle Scholar
  38. Kirby, K. N., Petry, N. M., & Bickel, W. K. (1999). Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. Journal of Experimental Psychology: General, 128, 78–87.CrossRefGoogle Scholar
  39. Kross, E., Berman, M. G., Mischel, W., Smith, E. E., & Wager, T. D. (2011). Social rejection shares somatosensory representations with physical pain. PNAS, 108(15), 6270–6275.CrossRefPubMedPubMedCentralGoogle Scholar
  40. Kruger, D. J., & Kruger, J. S. (2016). Psychometric assessment of human life history predicts health related behaviors. Psychological Topics, 25, 19–28.Google Scholar
  41. Landes, R. D., Christensen, D. R., & Bickel, W. K. (2012). Delay discounting decreases in those completing treatment for opioid dependence. Experimental and Clinical Psychopharmacology, 20(4), 302–309.CrossRefPubMedPubMedCentralGoogle Scholar
  42. LeBlanc, D. M., McGinn, M. A., Itoga, C. A., & Edwards, S. (2015). The affective dimension of pain as a risk factor for drug and alcohol addiction. Alcohol, 49, 803–809.CrossRefPubMedPubMedCentralGoogle Scholar
  43. Liberson, I., Taylor, S. F., Phan, K. L., Britton, J. C., Fig, L. M., Bueller, J. A., … Zubieta, J.-K. (2007). Altered central mu-opioid receptor binding after psychological trauma. Biological Psychiatry, 61, 1030–1038.CrossRefGoogle Scholar
  44. Lutz, P. E., & Kieffer, B. L. (2013a). Opioid receptors: Distinct roles in mood disorders. Trends in Neurosciences, 36(3), 195–206.CrossRefPubMedGoogle Scholar
  45. Lutz, P. E., & Kieffer, B. L. (2013b). The multiple facets of opioid receptor function: Implications for addiction. Current Opinion in Neurobiology, 23(4), 473–479.CrossRefPubMedPubMedCentralGoogle Scholar
  46. Machin, A. J., & Dunbar, R. I. M. (2011). The brain opioid theory of social attachment: A review of the evidence. Behaviour, 148, 985–1025.CrossRefGoogle Scholar
  47. MacLean, P. D. (1985). Brain evolution relating to family, play, and the separation call. Archives of General Psychiatry, 42, 405–417.CrossRefPubMedGoogle Scholar
  48. MacKillop, J., Amlung, M. T., Few, L. R., Ray, L. A., Sweet, L. H., & Munafo, M. R. (2011). Delayed reward discounting and addictive behavior: A meta-analysis. Psychopharmacology, 216, 305–321.CrossRefPubMedPubMedCentralGoogle Scholar
  49. Mansour, A., Fox, C. A., Burke, S., Meng, F., Thompson, R. C., Akil, H., & Watson, S. J. (1994). Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study. Journal of Comparative Neurology, 350(3), 412–438.CrossRefPubMedGoogle Scholar
  50. Martel, F. L., Nevison, C. M., Simpson, M. J. A., & Keverne, E. B. (1995). Effects of opioid receptor blockade on the social behavior of rhesus monkeys living in large family groups. Developmental Psychobiology, 28, 71–84.CrossRefPubMedGoogle Scholar
  51. Mattick, R. P., Ali, R., White, J. M., O’Brien, S., Wolk, S., & Danz, C. (2013). Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98, 441–452.CrossRefGoogle Scholar
  52. Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews Issue, 3. doi: 10.1002/14651858.CD002209.pub2.
  53. Meller, R. E., Keverne, E. B., & Herbert, J. (1980). Behavioural and endocrine effects of naltrexone in male talapoin monkeys. Pharmacology, Biochemistry, and Behavior, 13, 663–672.CrossRefPubMedGoogle Scholar
  54. Mestek, A., Chen, Y., & Yu, L. (1996). Mu opioid receptors: Cellular action and tolerance development. NIDA Research Monographs, 161, 104–126.Google Scholar
  55. Meyer, J. S., & Quenzer, L. F. (2013). Psychopharmacology: Drugs, the brain, and behavior. Sunderland, NY: Sinauer.Google Scholar
  56. Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (2nd ed.). New York: Guilford Press.Google Scholar
  57. Mulligan, C. J., Robin, R. W., Osier, M. V., Sambuughin, N., Goldfarb, L. G., Kittles, R. A., … Long, J. C. (2003). Allelic variation at alcohol metabolism genes (ADH1B, ADH1C, ALDH2) and alcohol dependence in an American Indian population. Human Genetics, 113(4), 325–336.CrossRefPubMedGoogle Scholar
  58. Narcotics Anonymous (NA) World Services. (2016). Bulletin #29: Regarding methadone and other drug replacement programs. Retrieved 20 December, from
  59. Nelson, E. E., & Panksepp, J. (1998). Brain substrates of infant-mother attachment: Contributions of opioids, oxytocin and norepinephrine. Neuroscience and Biobehavioral Reviews, 22, 437–452.CrossRefPubMedGoogle Scholar
  60. Nesse, R. M. (2016). Evolutionary psychology and mental health. In D. M. Buss (Ed.), The handbook of evolutionary psychology: Volume 2 integrations (2nd ed.pp. 1007–1026). New York, NY: Wiley.Google Scholar
  61. Nesse, R. M., & Berridge, K. C. (1997). Psychoactive drug use in evolutionary perspective. Science, 278, 63–66.CrossRefPubMedGoogle Scholar
  62. Nestler, E. J., Hyman, S. E., & Malenka, R. C. (2009). Molecular neuropharmacology: A foundation for clinical neuroscience (2nd ed.). New York, NY: McGraw-Hill.Google Scholar
  63. Noirot, E. (1972). Ultrasounds and maternal behavior in small rodents. Developmental Psychobiology, 5, 371–387.CrossRefPubMedGoogle Scholar
  64. Novak, S. P., Håkansson, A., Martinez-Raga, J., Reimer, J., Krotki, K., & Varughese, S. (2016). Nonmedical use of prescription drugs in the European Union. BMC Psychiatry, 16, 274. doi: 10.1186/s12888-016-0909-3.CrossRefPubMedPubMedCentralGoogle Scholar
  65. Nummenmaa, L., Tuominen, L., Dunbar, R., Hirvonen, J., Manninen, S., … Sams, M. (2016). Social touch modulates endogenous μ-opioid system activity in humans. NeuroImage, 138, 242–247.CrossRefPubMedGoogle Scholar
  66. O’Connell, L. A., & Hofmann, H. A. (2011a). Genes, hormones, and circuits: An integrative approach to study the evolution of social behavior. Frontiers in Neuroendocrinology, 32, 320–335.CrossRefPubMedGoogle Scholar
  67. O’Connell, L. A., & Hofmann, H. A. (2011b). The vertebrate mesolimbic reward system and social behavior network: A comparative synthesis. The Journal of Comparative Neurology, 519, 3599–3639.CrossRefPubMedGoogle Scholar
  68. Odendaal, J. S. J., & Meintjes, R. A. (2003). Neurophysiological correlates of affiliative behavior between humans and dogs. The Veterinary Journal, 165, 296–301.CrossRefPubMedGoogle Scholar
  69. Okon, E. E. (1970). The effect of environmental temperature on the production of ultrasounds by isolated non-handled albino mouse pups. Journal of Zoology. London, 162, 71–83.CrossRefGoogle Scholar
  70. Olds, J. (1977). Drives and reinforcements: Behavioral studies of hypothalamic functions. New York: Raven Press.Google Scholar
  71. Palomar, J. J., Shearston, J. A., Dawson, E. W., Mateu-Gelabert, P., & Ompad, D. C. (2016). Nonmedical opioid use and heroin use in a nationally representative sample of high school seniors. Drug and Alcohol Dependence, 158, 132–138.CrossRefGoogle Scholar
  72. Panksepp, J. (1998). Affective neuroscience. New York, NY: Oxford University Press.Google Scholar
  73. Panksepp, J. (2003). Feeling the pain of social loss. Science, 302, 237–239.CrossRefPubMedGoogle Scholar
  74. Panksepp, J., Bean, N. J., Bishop, P., Vilberg, T., & Sahley, T. L. (1980). Opioid blockade and social comfort in chicks. Pharmacology, Biochemistry and Behavior, 13, 673–683.CrossRefPubMedGoogle Scholar
  75. Panksepp, J., Herman, B. H., Conner, R., Bishop, P., & Scott, J. P. (1978). The biology of social attachments: Opiates relieve separation distress. Biological Psychiatry, 13, 607–613.PubMedGoogle Scholar
  76. Panksepp, J., Knutson, B., & Burgdorf, J. (2002). The role of brain emotional systems in addictions: A neuro-evolutionary perspective and a new ‘self-report’ animal model. Addiction, 97, 459–469.CrossRefPubMedGoogle Scholar
  77. Peckys, D., & Landwehrmeyer, G. B. (1999). Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: A 33 P in situ hybridization study. Neuroscience, 88(4), 1093–1135.CrossRefPubMedGoogle Scholar
  78. Price, D. D. (2000). Psychological and neural mechanisms of the affective dimension of pain. Science, 288(5472), 1769–1772.CrossRefPubMedGoogle Scholar
  79. Price, D. D. (2002). Central neural mechanisms that interrelate sensory and affective dimensions of pain. Molecular Interventions, 2(6), 392.CrossRefPubMedGoogle Scholar
  80. Putnam, R. D. (2001). Bowling alone: The collapse and revival of American community. New York, NY: Simon and Schuster.Google Scholar
  81. Ren, Z.-Y., Shi, J., Epstein, D. H., & Wang, J. (2009). Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving. Psychopharmacology, 204, 423–429.CrossRefPubMedPubMedCentralGoogle Scholar
  82. Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization view. Addiction, 95(Suppl. 2), S91–S117.Google Scholar
  83. Schultz, S., & Dunbar, R. I. M. (2007). The evolution of the social brain: Anthropoid primates contrast with other vertebrates. Proceedings of the Royal Society, Series B, 274, 2429–2436.CrossRefGoogle Scholar
  84. Seiger, B. (2014). The clinical practice of harm reduction psychotherapy. In S. L. A. Straussner (Ed.), Clinical work with substance-abusing clients (pp. 165–178). New York, NY: Guilford Press.Google Scholar
  85. Sewell, G. D. (1970). Ultrasonic communication in rodents. Nature (London), 227(256), 410.CrossRefGoogle Scholar
  86. Shayit, M., Nowak, R., Keller, M., & Weller, A. (2003). Establishment of a preference by the newborn lamb for its mother: The role of opioids. Behavioral Neuroscience, 117, 446–454.CrossRefPubMedGoogle Scholar
  87. Shippenberg, T. S. (1993). Motivational effects of opioids. InOpioids II. Berlin Heidelberg: Springer.Google Scholar
  88. Smith, Y. R., Stohler, C. S., Nichols, T. E., Bueller, J. A., Koeppe, R. A., & Zubieta, J. K. (2006). Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. Journal of Neuroscience, 26, 5777–5785.CrossRefPubMedPubMedCentralGoogle Scholar
  89. Song, F. W. (2009). Virtual communities: Bowling alone, online together. New York, NY: Peter Lang.Google Scholar
  90. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality (SAMHSA). (2014). The NSDUH report: Substance use and mental health estimates from the 2013 national survey on drug use and health: Overview of findings. Rockville, MD. Retrieved from
  91. Vest, N., Reynolds, C. J., & Tragesser, S. L. (2016). Impulsivity and risk for prescription opioid misuse in a chronic pain patient sample. Addictive Behaviors, 60, 184–190.CrossRefPubMedGoogle Scholar
  92. Volkow, N. D. (2014). America’s addiction to opioids: Heroin and prescription drug abuse. Senate Caucus on International Narcotics Control. Washington, DC.Google Scholar
  93. Vuchinich, R. E., & Simpson, C. A. (1998). Hyperbolic temporal discounting in social drinkers and problem drinkers. Experimental and Clinical Psychopharmacology, 6, 292–305.CrossRefPubMedGoogle Scholar
  94. Way, B. M., Taylor, S. E., & Eisenberger, N. I. (2009). Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection. Proceedings of the National Academy of Sciences, USA, 106, 15079–15084.CrossRefGoogle Scholar
  95. White, J. L., Moffitt, T. E., Caspi, A., Bartusch, D. J., Needles, D. J., & Stouthamer-Loeber, M. (1994). Measuring impulsivity and examining its relationship to delinquency. Journal of Abnormal Psychology, 103(2), 192–205.CrossRefPubMedGoogle Scholar
  96. Wilson, M., & Daly, M. (1985). Competitiveness, risk taking, and violence: The young male syndrome. Ethology and Sociobiology, 6, 59–73.CrossRefGoogle Scholar
  97. Wright, E. R., Kooreman, H. E., Greene, M. S., Chambers, R. A., Banerjee, A., & Wilson, J. (2014). The iatrogenic epidemic of prescription drug abuse: County-level determinants of opioid availability and abuse. Drug and Alcohol Dependence, 138, 209–215.CrossRefPubMedGoogle Scholar
  98. Yoo, J. H., Lee, S. Y., Loh, H. H., Ho, I. K., & Jang, C. G. (2004). Altered emotional behaviors and the expression of 5-HT1A and M1 muscarinic receptors in μ-opioid receptor knockout mice. Synapse, 54(2), 72–82.CrossRefPubMedGoogle Scholar
  99. Zubieta, J. K., Ketter, T. A., Bueller, J. A., Xu, Y., Kilbourn, M. R., … Koeppe, R. A. (2003). Regulation of human affective responses by anterior cingulate and limbic μ-opioid neurotransmission. Archives of General Psychiatry, 60(11), 1145–1153.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Elizabeth M. Hill
    • 1
    Email author
  • Lindsey Hunt
    • 1
  • Daniel G. Duryea
    • 2
  1. 1.Department of PsychologyUniversity of Detroit MercyDetroitUSA
  2. 2.Department of Counseling and Addiction StudiesUniversity of Detroit MercyDetroitUSA

Personalised recommendations